["{\n\"step_by_step_thinking\": \"The question is about the expected beneficial effect of a drug that caused a patient's symptoms. The patient received neoadjuvant chemotherapy 1 week ago. One of the complications mentioned in the documents is myelosuppressive complication, which is associated with intravesical instillations of thiotepa. However, since this patient has a sensorineural hearing loss, it is unlikely that the drug caused this symptom through myelosuppression. The relevant document that mentionsotoxicity is [Undifferentiated carcinoma of the ear: apropos of a case]. This suggests that the patient's symptoms are related to ototoxocity.\",\n\"answer_choice\": C\n}"]